Missouri Physician Genetic-Testing Fraud: Signing for Results He Would Never Use

A St. Peters, Missouri, physician admitted in a telemedicine guilty plea to false statements behind more than $1.4 million in Medicare and Medicaid genetic-testing fraud. He signed forms promising the results would guide treatment, while knowing he would never receive or use the reports. According to the Justice Department’s account of the plea, a company paid him $30 per consultation. His signatures went onto orders that laboratories used to bill Medicare and Medicaid. The paperwork promised patient care. The physician knew his work would end before the results arrived.

The Certification Promised Care the Physician Would Never Provide

In his guilty plea to conspiring to make false statements related to health care matters, the physician admitted that he had a doctor-patient relationship with very few, if any, of the beneficiaries for whom he ordered genetic testing. He provided no follow-up care. Yet the pre-printed forms he signed certified both that the testing was medically necessary and that its results would determine the patient’s medical management and treatment decisions.

The physician knew he would not receive the reports or use them to treat the patients. The falsehood was already there when he signed.

The promise about using the results came with the pre-printed form. A laboratory could receive an order with a medical-necessity certification attached, while the patient had no follow-up care from the person who signed it.

From a Paid Consultation to a Laboratory Claim

The criminal plea account says the physician contracted with a business identified in court documents as Company A. He used electronic portals to receive patient information and sign forms, orders and letters of medical necessity. The orders then went to laboratories, which submitted claims for the genetic tests.

The consultation payment and the laboratory payment sat at different points in the same transaction. Company A paid for the physician’s work. The laboratories billed the public programs. The signed order connected the remote review to a service another business could charge for.

That division is part of the business model an insider needs to understand. A telehealth arrangement can separate clinical work, platform operation, staffing and billing among different businesses. The clinician’s contract describes the paid work. The portal carries the information and signature. The laboratory claim asks the payer for money. Looking at the consultation alone leaves the later transaction out of view.

The Department of Health and Human Services Office of Inspector General described this broader mechanism in its July 20, 2022 telemedicine alert: companies recruit patients and practitioners, supply information, compensate reviews or signatures, and transfer orders to downstream buyers. An order can be the commercial output of the arrangement, even when the person signing it sees the work as a consultation.

What the Physician Knew About the Laboratory Payments

The Justice Department’s plea account says many of the laboratories paid illegal kickbacks to people and businesses involved in submitting false claims, without the physician’s knowledge. It also says he knew his own statements about using the results were false.

The physician’s admission concerned a promise within his own control: what he would do with the test results. The laboratory kickbacks were a separate part of the government’s account.

For a clinician who recognizes the forms, or a billing employee who sees where the orders go, the useful connection is between the statement signed and the work actually expected. The people handling those records can see different parts of the same transaction.

Medicare and Medicaid Paid for the Ordered Tests

In his guilty plea, the physician admitted that his genetic-test orders caused Medicare to pay approximately $1,030,906 to laboratories from March 2017 to September 2019. He also admitted that his orders caused Medicaid to pay approximately $376,981 from November 2018 to October 2019.

Company A bought consultations. Taxpayers paid for the resulting laboratory tests, while the physician who signed the treatment assurances provided no follow-up care.

What Is a Red Flag for Health Care Fraud?

A certification that promises care the signer knows will never happen is a red flag for health care fraud. This case makes that concern concrete: the physician admitted signing a statement about treatment decisions while knowing he would not receive the reports needed to make them.

The Inspector General’s telemedicine alert identifies insufficient patient contact or information and missing follow-up among suspect features. In this case, the admission supplies the decisive connection between the form and the physician’s knowledge. The signed assurance and the actual plan for the results directly contradicted each other.

What Evidence Is Needed to Report Fraud?

Telehealth fraud evidence in this case centers on the signed promise to use test results. We compare that promise with the consultation records and expected delivery of reports, then trace the signed order through portal history to the laboratory claim and payment.

An insider may also know who supplied the form language and whether anyone expected the ordering clinician to receive the results. That knowledge gets directly to the mismatch in this case. Our whistleblower experts work with you to connect what you saw inside the business to the claims it produced.

When Portal Approval Generates the Billing Documents

In a separate Delaware civil settlement’s statement of facts, a physician admitted that approval through MySpecialistMD generated signed genetic-test documents for laboratory billing. That portal-approval case shows why an insider’s knowledge of the approval process can matter alongside the finished forms.

The Whistleblower’s View of the Signed Order

The Missouri case shows how knowledge inside a consultation arrangement can explain laboratory claims further down the chain. A healthcare insider who knows the forms, the payment terms or the plan for test results may hold the connection between a signed assurance and the care that never followed. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know What the Signature Meant

If you worked with genetic-test forms that promised care the signer never intended to provide, speak with our whistleblower experts about what happened behind the signature. Our experts stay with you as we build your strongest telehealth whistleblower case around that gap and bring in telehealth fraud whistleblower lawyers who understand the handoff from an online signature to a paid laboratory claim.